Stable Knockout Cell Line Generation
2026-02-25 14:30:57
source:
本站
page views:4

About Us

未命名.pngNebulabio is a cell engineering team specializing in mammalian stable cell line development for research and discovery workflows. By integrating standardized project execution with flexible genome editing strategies, we deliver assay-ready knockout cell lines with clear documentation, traceable milestones, and practical quality control—enabling consistent, reproducible experiments that support confident interpretation of loss-of-function phenotypes.


Our Stable Cell Line Platform

Our platform spans knockout strategy and guide design, gene delivery and enrichment, establishment of stable edited populations with optional single-cell cloning, and systematic genotype and phenotype validation, followed by quality control and cell banking. The resulting knockout cell lines are genetically defined research tools suitable for mechanistic studies, pathway analysis, assay development, and screening workflows.




Supported Knockout Options

■ Host Cell Lines (HEK293 / CHO / Customer-Provided Lines):

  • Commonly used mammalian hosts are supported, and customer-supplied or disease-relevant cell lines may be accepted following feasibility evaluation, particularly for difficult-to-edit models.

■ Knockout Strategies (How Disruption Is Achieved):

  • CRISPR/Cas9 indel knockout: frameshift disruption via NHEJ; the most common approach for protein-coding genes

  • Dual-guide deletion (optional): removal of a defined genomic region, useful for functional domains, regulatory elements, or challenging loci

  • Multiplex knockout (optional): simultaneous disruption of multiple genes to address pathway redundancy

  • Conditional or inducible knockout (optional): controlled gene disruption for essential genes or toxicity-sensitive targets

■ Editing Design Options:

  • Target full coding exons versus specific functional domains

  • Monoallelic versus biallelic disruption (defined by biology and assay requirements)

  • Rescue-ready designs (optional), enabling knockout plus add-back strategies for specificity validation

■ Delivery Methods (Transfection / Electroporation / Viral, When Applicable):


  • Multiple delivery routes are available to match cell type, editing efficiency needs, and project timelines.

■ Stable Pools (Polyclonal) vs. Single-Cell Derived Clones:

  • Polyclonal knockout pools support rapid feasibility assessment, while monoclonal knockout lines provide genotype certainty and uniform loss-of-function behavior for high-stringency applications.

■ Validation Readouts (Genotype + Protein / Function):

  • Genotyping by PCR and Sanger sequencing (with project-defined deeper validation when required)

  • Protein-level confirmation by Western blot, flow cytometry, or immunofluorescence

  • Functional verification through pathway activity, phenotype assays, or growth impact assessment


       ☎  +86-15801534258           ✉  info@nebulabio.cn       Request a Quote   



Principle of Stable Knockout Cell Lines

Stable knockout cell lines are generated by introducing genome editing reagents that create loss-of-function mutations at a defined target locus. In the most common CRISPR/Cas9-based approach, guide RNAs direct Cas9 to the target site, and repair by non-homologous end joining (NHEJ) produces insertions or deletions that disrupt the coding sequence—frequently resulting in frameshifts and premature stop codons.


Nebulabio Service Workflow

图片1.png


 1. Project Design & Input Preparation 

We translate your biological question into a buildable, assay-oriented stable knockout strategy.

Project Scoping:

  • Confirm target gene (species, transcript/isoform if relevant).

  • Define knockout type: indel knockout, dual-guide deletion, multiplex knockout, or conditional/inducible knockout.

  • Select host cell line (HEK293 / CHO / customer-provided).

  • Clarify downstream assays and experimental objectives.

  • Assess essentiality and viability considerations (if applicable).

  • Define acceptance criteria (genotype requirements and protein/functional benchmarks).

Input Options:

  • Provide target gene name and transcript/isoform preference, or

  • Provide preferred sgRNA sequences (if already designed), or

  • Provide existing plasmids or genome editing reagents (optional).

Recommended Output Tier:

  • Stable knockout pool (polyclonal) for feasibility and early-stage assays, or

  • Single-cell–derived knockout clone(s) for genotype certainty and high-stringency applications.



 2. Guide Design & Editing Reagent Preparation 

We design and prepare the genome editing reagents required for robust knockout generation.

Key Steps:

  • sgRNA design with target region rationale.

  • Editing construct preparation in delivery-ready format (project-dependent).

  • Optional: enrichment strategy design

QC & Documentation:

  • Editing design summary (target exon/region, guide positions, expected disruption outcome).

  • Construct or reagent preparation record (project-dependent).



 3. Gene Delivery & Stable Pool Establishment 

We introduce genome editing reagents into host cells and establish a stable edited population.

Key Steps:

  • Gene delivery options: transfection / electroporation / project-specific delivery approach.

  • Recovery and enrichment: optional drug selection or cell sorting if enrichment markers are used.

  • Pool expansion: stabilization and expansion of edited cells.

  • Early genotype check: rapid pool-level screen to confirm editing before clonal isolation (when feasible).

Common Methods (as applicable):

  • Drug-based selection.

  • FACS enrichment (optional).

  • Sub-culturing and population stabilization.



 4. Single-Cell Clone Generation (Optional but common for Knockout) 

When precise genotype definition and uniform loss-of-function are required, we isolate and screen single-cell–derived clones.

Key Steps:

  • Single-cell isolation: limiting dilution or single-cell sorting

  • Clonal expansion: recovery and scale-up.

  • Primary screening: PCR and sequencing to define indel or deletion patterns and assess zygosity.

What you get (clone tier):

  • A shortlist of validated knockout clones (number configurable).

  • Screening summary table (genotype definition and growth observations).



 5. Validation, Genotype Confirmation & QC 

We confirm the knockout at the DNA level and verify loss-of-function using fit-for-purpose assays.

Core Validation Options (project-dependent):

  • PCR across target regions (and deletion junction PCR when applicable).

  • Sanger sequencing of edited alleles.

  • Zygosity assessment (monoallelic vs. biallelic disruption, as requested).

Protein / Functional Validation:

  • Western blot, flow cytometry, or immunofluorescence to confirm protein loss (where detectable).

  • Functional assays to verify pathway or phenotype changes.

  • Growth and fitness observation, particularly for essential genes.

QC (Recommended):

  • Mycoplasma testing (standard).

  • Sterility and contamination checks (as applicable).




 6.Cell Banking & Delivery 

We cryopreserve and deliver the final stable knockout pool or clone(s) with a complete documentation package.

Deliverables (Industry-Standard):

  • Cryopreserved stable knockout cells (multiple vials).

  • COA / QC summary (including configured QC items).

  • Genotyping data package (PCR and sequencing results).

  • Protein and/or functional validation data (as applicable).

  • Culture and recovery guidance (recommended passage window and assay notes).



Featured Applications of Stable Knockout Cell Lines

  • Loss-of-Function Validation:Knockout cell lines provide definitive genetic evidence for target dependency, enabling unambiguous assessment of gene function through complete loss-of-function.

Loss-of-Function Validation


  • Mechanism-of-Action and Pathway Analysis: Stable knockout models support systematic dissection of signaling pathways, feedback regulation, and resistance mechanisms under genetically defined conditions.

Mechanism-of-Action and Pathway Analysis


  • Drug Sensitivity and Resistance Models: Gene knockout cell lines are widely used to evaluate how complete target loss alters cellular responses to small molecules, biologics, or combination treatments.

Drug Sensitivity and Resistance Models


  • Screening Enablement: Genetically defined knockout cell lines provide robust platforms for genetic or pharmacological screening with reduced background ambiguity and improved interpretability.

Screening Enablement


 For more information, please contact us at info@nebulabio.cn or +86-15801534258.